LBGCX
Price
$37.55
Change
+$0.58 (+1.57%)
Updated
Nov 8 closing price
PAMCX
Price
$107.33
Change
+$0.42 (+0.39%)
Updated
Nov 8 closing price
Ad is loading...

LBGCX vs PAMCX

Header iconLBGCX vs PAMCX Comparison
Open Charts LBGCX vs PAMCXBanner chart's image
ClearBridge Mid Cap Growth C
Price$37.55
Change+$0.58 (+1.57%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$107.33
Change+$0.42 (+0.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LBGCX vs PAMCX Comparison Chart
Loading...
VS
LBGCX vs. PAMCX commentary
Nov 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBGCX is a Buy and PAMCX is a Buy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 32.1B vs. LBGCX (277M). LBGCX (0.00) and PAMCX (0.00) have matching dividends . LBGCX was incepted earlier than PAMCX: LBGCX (14 years) vs PAMCX (25 years). PAMCX is a more actively managed with annual turnover of: 21.70 vs. LBGCX (14.00). LBGCX has a lower initial minimum investment than PAMCX: LBGCX (1000) vs PAMCX (2500). LBGCX annual gain was more profitable for investors over the last year : 42.23 vs. PAMCX (21.88). LBGCX return over 5 years is better than : 38.66 vs. PAMCX (16.32).
LBGCXPAMCXLBGCX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years25 years-
Gain YTD20.62312.967159%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets277M32.1B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year42.2321.88193%
Returns for 3 years-8.70-15.1957%
Returns for 5 years38.6616.32237%
Returns for 10 years66.0036.47181%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WORX1.180.03
+2.26%
SCWorx Corp
HTZ3.150.04
+1.29%
Hertz Global Holdings
HBT23.860.18
+0.76%
HBT Financial
FBIN79.05-0.07
-0.09%
Fortune Brands Innovations
COYA7.21-0.01
-0.14%
Coya Therapeutics